Introduction
============

Lower acute respiratory infections (ARIs) are a persistent and pervasive public health problem, since they constitute one of the main causes of morbidity and mortality, with greater burden of disease worldwide than human immunodeficiency virus infection, malaria, cancer, or heart attacks ([@ref-35]; [@ref-39]).

World Health Organization (WHO) data indicate influenza A viruses as the main viral agents causing ARI, and therefore of great epidemiological importance. Seasonal influenza epidemics, currently involving influenza A(H3N2), A(H1N1)pdm09 and B (Yamagata (Yam) and Victoria (Vic) lineages), affect 10--20% of the human population each year ([@ref-62]). According to new estimates by the United States Centers for Disease Control and Prevention, up to 650,000 deaths annually are associated with respiratory diseases from seasonal influenza ([@ref-60]). Although influenza B only infects humans, influenza A infects both humans and animals. Furthermore, humans can be infected with avian, swine and other zoonotic influenza viruses, such as A(H5N1), A(H7N9), and A(H9N2) subtypes ([@ref-61]).

The influenza A virus belongs to *Orthomyxoviridae* family. The genomic single stranded RNA (RNAss) is octa-segmented, negative-sense, surrounded by a helical capsid with externally lipoprotein envelope, in which glycoproteins hemagglutinin (HA) and neuraminidase (NA) are inserted ([@ref-3]). Frequently, minor modifications in these envelope proteins may alter the affinity of vaccine antibodies or inactivate them, preventing recognition of the virus by the immune system, causing repetitive influenza outbreaks worldwide. However, in rare moments the combination of the eight genomic segments (reassortment) can occur, such as between influenza animal and human subtypes. This event, named antigenic shift, can result in strains capable of causing large regional or global pandemic outbreaks ([@ref-66]).

The primary method of prevention is annual vaccination. Antiviral medications for prevention and treatment of influenza are an important adjunct to vaccines, especially for at-risk groups, including young children, older people, pregnant women and people with certain health conditions ([@ref-6]; [@ref-44]).

The most important class of antiviral recommended for the control of influenza epidemics and eventual pandemics is the Neuraminidase Inhibitors (NAIs), particularly oseltamivir (OST) and zanamivir (ZAN). These compounds are active against all influenza A subtypes and the two major influenza B lineages. Thus, the emergence of NAIs resistance could be a major clinical concern. Although most currently circulating influenza A and B strains are susceptible to NAIs, the pressure imposed by OST has led to the selection of OST-resistant mutants, with a prevalence of 1--2% in different countries ([@ref-10]; [@ref-27]; [@ref-54]). The OST-resistant strains with compensatory mutations may arise in an independent fashion, with samples being identified in different states of Brazil and in other countries ([@ref-27]). Reports have shown single or multiple substitutions or deletions in the NA gene, which can promote a phenotype cross-resistance to the two main NAIs (oseltamivir and zanamivir) used in clinics, mostly in immunocompromised individuals ([@ref-1]). Systematic circulation of these viral strains may jeopardise the use of the first line of anti-influenza drugs in the future. Thus, the search for new anti-influenza compounds is pivotal for public health.

Marine and freshwater natural products have been reported to contain different biological activities, which allow them to provide health and cosmetic benefits, such as antioxidant, anti-inflammatory, anticancer and antiviral activity, including against some respiratory viruses ([@ref-4]; [@ref-19]; [@ref-24]; [@ref-30]; [@ref-31]; [@ref-32]; [@ref-33]). Microalgae and cyanobacteria are huge natural sources of high-value compounds with health-promoting properties. These marine and freshwater organisms are a rich source of bioactive compounds such as vitamins, proteins with essential amino acids, polysaccharides, fatty acids, minerals, enzymes, fiber and photosynthetic pigments (carotenoids and chlorophylls) ([@ref-36]). The carotenoids contain a great compound range of different classes that are biosynthesized by condensation of isoprene units in (micro)algae and cyanobacteria ([@ref-15]; [@ref-22]; [@ref-46]).

The aim of this study is to evaluate the antiviral activity of natural extracts against influenza A and B, oseltamivir-sensitive and resistant strains and lineages. The 38 extracts were obtained from microalgae and cyanobacteria cultures isolated from fresh (Paraguaçu River and Lençois Maranhenses Lakes) and marine water (Abrolhos Bank and Guanabara Bay) biomes in Brazil. We evaluated these extracts for cellular toxicity, influenza replication and neuraminidase activity. The extracts presented low cytotoxicity, and 17 of them inhibited influenza replication in more than 80% *in vitro*, with two inhibiting neuraminidase activity from influenza A and B OST-sensitive and resistant. These data contribute to the knowledge of the biotechnological potential of Brazilian biomes, which are underexplored for antiviral research and bioprospecting.

Materials and Methods
=====================

Origin of microalgae and cyanobacteria strains
----------------------------------------------

Microalgae and cyanobacteria strains used in this study belong to the Culture Collection of Microalgae at UFRJ (CCMR, Marine Phytoplankton Laboratory, Federal University of Rio de Janeiro). These strains were isolated by single-cell sorting in a flow cytometer ([@ref-12]) and are maintained in culture by successive transfers to fresh liquid medium at 3--6 week intervals, depending on the species. All 26 strains used here are originated from fresh (Paraguaçu River and Shallow Lake System of Lençois Maranhenses) and marine water (Guanabara Bay estuary and Abrolhos coral reefs) biomes in Brazil ([Table 1](#table-1){ref-type="table"}). Taxonomic identification of the strains was based on morphology and, for most of them, also on DNA sequencing (SSU rDNA) ([@ref-12]). The field experiments were approved by Ministério do Meio Ambiente (MMA), Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio) and Sistema de Autorização e Informação em Biodiversidade (SISBIO), approval number: 35854-2. The access to genetic heritage was approved by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), approval number: 010339/2014-0; and Sistema Nacional de Gestão do Patrimônio Genético e do Conhecimento Tradicional Associado (SisGen), approval number: A03D5C4.
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###### Extracts identification and collection specifications.

![](peerj-06-5716-g002)

  **Extract identification**   **Taxon**                                             **Source**   **Collection point**        **Latitude**    **Longitude**   **Collection data**
  ---------------------------- ----------------------------------------------------- ------------ --------------------------- --------------- --------------- ---------------------
  1                            Unidentified filamentous green algae                  Freshwater   Lençois Maranhenses Lakes   2°32′11″S       41°51′10″W      August, 2012
  2                            *Staurastrum* sp.                                     Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  3                            Unidentified filamentous green algae                  Freshwater   Paraguaçu River             12°57′8.48″S    41°16′39.29″W   November, 2012
  4                            *Scenedesmus* sp.                                     Freshwater   Lençois Maranhenses Lakes   12°50′25.91″S   41°19′26.52″W   November, 2012
  5                            *Leptolyngbya* sp.[^a^](#table-1fn1){ref-type="fn"}   Marine       Abrolhos Bank               17°59′52.8″S    38°40′15.6″W    October, 2013
  6                            Unidentified coccoid green algae                      Freshwater   Paraguaçu River             12°57′8.48″S    41°16′39.29″W   November, 2012
  7                            Unidentified coccoid green algae                      Freshwater   Lençois Maranhenses Lakes   12°50′25.91″S   41°19′26.52″W   November, 2012
  8                            *Scenedesmus abundans*                                Freshwater   Lençois Maranhenses Lakes   2°32′11″S       41°51′10″W      August, 2012
  9                            *Scenedesmus vacuolatus*                              Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  10                           *Chlamydomonas angulosa*                              Freshwater   Lençois Maranhenses Lakes   2°38′50″S       42°49′43″W      August, 2012
  11                           Chlorellaceae                                         Freshwater   Lençois Maranhenses Lakes   2°38′50″S       42°49′43″W      August, 2012
  12                           Desmidiaceae                                          Freshwater   Lençois Maranhenses Lakes   2°35′08″S       42°48′03″W      August, 2012
  13                           *Chlamydomonas sp.*                                   Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  14                           *Selenastrum* sp.                                     Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  15                           Scenedesmaceae                                        Freshwater   Lençois Maranhenses Lakes   2°33′42″S       42°51′49″W      August, 2012
  16                           Unidentified coccoid green algae                      Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  17                           *Leptolyngbya* sp.[^a^](#table-1fn1){ref-type="fn"}   Marine       Abrolhos Bank               12°50′25.91″S   41°19′26.52″W   November, 2012
  18                           *Desmodesmus armatus*                                 Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  19                           *Symbiodinium* sp.                                    Marine       Abrolhos Bank               17°57′32.7″S    38°30′20.3″W    March, 2012
  20                           *Chattonella sp.*                                     Marine       Guanabara Bay               22°50′01.0″S    43°12′29.0″W    January, 2016
  21                           Chlorellaceae                                         Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  22                           *Desmodesmus perforatus*                              Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  23                           Chlorellaceae                                         Freshwater   Lençois Maranhenses Lakes   2°32′11″S       41°51′10″W      August, 2012
  24                           Desmidiaceae                                          Freshwater   Lençois Maranhenses Lakes   2°30′10″S       42°51′50″W      August, 2012
  25                           *Romeria* sp.[^a^](#table-1fn1){ref-type="fn"}        Marine       Abrolhos Bank               18°00′13.0″S    39°14′57.0″W    February, 2014
  26                           *Nanofrustulum shiloi*                                Marine       Abrolhos Bank               17°57′07.0″S    39°13′11.0″W    February, 2013

**Notes.**

Cyanobacteria strains.

Microalgae and cyanobacteria cultivation
----------------------------------------

Microalgae and cyanobacteria were grown in autoclaved sterile medium at 26 ± 1 °C, with a photon flux of ca. 300 µmoles photon m^−2^ s^−1^ and 16 h light: 8 h dark photoperiod. Freshwater strains were grown in ASM-1 medium whereas marine strains were grown in f/2 medium ([@ref-16]; [@ref-17]; [@ref-42]). Cultures were grown in glass balloons with 300--500 mL of culture medium for 3--6 weeks, depending on the growth rate of each strain. The cultures were stored at −80 °C until extracts production.

Extracts production
-------------------

All the microalgae and cyanobacteria cultures (cells and culture medium) were frozen, thawed and filtered through cheesecloth. The filtrate was extracted three times with ethyl acetate (added ratio 1:1 of volume) and three times with n-butanol (added ratio 1:1 of volume). The organic layers were concentrated under reduced pressure to dryness. A total of 38 extracts were produced, 26 in ethyl acetate (EtOAc) and 12 in n-butanol (n-BuOH). The crude extracts were stored at −20 °C until analysis. The extracts from one to 12 strains were obtained in the first batch with both solvents. After the screening test for anti-influenza activity, the second batch of extracts was produced from 13 to 26 strains, and they were solely obtained with ethyl acetate. Dried extracts were resuspended in dimethyl sulfoxide (DMSO) in a final concentration of 100 mg/mL for the *in vitro* tests. All the extracts were analyzed by TLC, HPLC, and Mass Spectrometry (MS). However, we could not identify any compounds, but the chemical profiles of the active extracts were preserved. Thus, the procedure must be repeated on a larger scale for the more active anti-influenza extracts. The chromatograms and mass spectra for extracts 5 and 21 are provided in the [File S1](#supp-1){ref-type="supplementary-material"} (*S01*).

Cells and virus
---------------

Madin-Darby canine kidney (MDCK) cells (London line) were kindly donated by the Centers for Disease Control and Prevention (CDC), Influenza Reagent Resources (IRR) (FR-58). These cells were used for cytotoxicity analysis, viral growth and experimental assays with influenza virus infection. These cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Waltham, MA, USA) supplemented with 10% of *fetal bovine serum (FBS;* Gibco) and 100 U/mL penicillin and 100 mg/mL streptomycin (Sigma-Aldrich, St. Louis, MO, USA). Cells were cultured at 37 °C in 5% CO~2~ atmosphere ([@ref-57]).

The viruses were grown and titrated according to WHO manual for the laboratory diagnosis and virological surveillance of influenza ([@ref-59]). The virus titration was performed by 50% Tissue Culture Infectious Dose (TCID~50~) assay. We analyzed the inhibitory effect of the extracts against influenza A strains and B lineages, OST-sensitive (Wild type---WT) and resistant (mutant): A/California/04/2009 (A(H1N1)pdm09-WT); A/Perth/261/2009 (A(H1N1)pdm09-H275Y); A/Switzerland/9715293/2013 (A(H3N2)-WT); B/Phuket/3073/2013 Yam (WT); B/Brisbane/60/2008 Vic (WT); B/Perth/211/2001 Yam (WT) and B/Perth/211/2001 Yam (D197E). All the viruses were kindly provided by the International Society for Influenza and other Respiratory Viruses Diseases-Antiviral Group (isirv-AVG) and CDC --IRR.

Cytotoxicity assay
------------------

One hundred microliters of 2.0 × 10^4^ MDCK cells were seeded into the 96-well culture plates (flat bottom) and grown for 24 h at 37 °C in a 5% CO~2~ atmosphere, then, the extracts were added with a final concentration of 1 mg/mL in DMEM. Control cells were treated with 1.0% DMSO, which did not affect the growth of the cells. The extracts were diluted in culture medium DMEM, the DMSO final concentration was equal to 1.0% (v/v). After 48 h of cells incubation with extracts or vehicle (DMSO), a freshly prepared XTT (Sigma) solution was added, as specified by the manufacturer's instructions. The XTT is a colorless or slightly yellow compound that is reduced to formazan (bright orange) by mitochondrial dehydrogenases of viable cells, as described before ([@ref-43]; [@ref-48]). The cell viability was calculated by the comparison between absorbance (A475 nm--A660 nm) from treated (A) and untreated (B) cells using the formula: A/B × 100. Tests were carried out performing three replicates (*n* = 3).

Screening of extracts on viral replication
------------------------------------------

Initially, we performed a screening to evaluate the inhibitory effect of the extracts. MDCK cells (2.0 × 10^5^ cells/well) were seeded in 24-well tissue culture plates and incubated overnight. Then, the monolayers of cells were infected with A(H1N1)pdm09-WT or A(H3N2)-WT at 400 TCID~50~ per well during 1 h at 37 °C and 5% CO~2~. After, the viral suspension was removed and the monolayers were treated with 200 µg/mL of each extract. There is no established protocol or concentration for the anti-influenza screening of crude extracts of natural products. There are papers that use 2 mg/ml as the maximum concentration, while others use 100 µg/ml ([@ref-9]; [@ref-13]; [@ref-40]; [@ref-50]; [@ref-52]). At 48 h post-infection (hpi), the supernatant was harvested to quantify the influenza titer. For this purpose, the supernatants were diluted 1:5 in NA-Star buffer and the neuraminidase activity was analyzed in triplicate by the NA-StarTM assay kit (Life Technologies, Carlsbad, CA, USA), according to the manufacturer's instructions. The antiviral activity of the extracts was calculated with respect to virus control only.

EC~50~ determination
--------------------

Half maximal effective concentration was determined for the extract that inhibited influenza replication in more than 80%. MDCK cells were seeded and infected as described above. After 1 hpi, the viral suspension was removed and the monolayers were treated with different extract concentrations (400 − 12.5 µg/mL). Oseltamivir carboxylate (100 − 3.2 µM) (OST-car; kindly donated by Hoffman-La Roche Inc., Basel, Switzerland) was used as a control. For influenza titration, the supernatants were harvested at 48 hpi, and the influenza virus was titrated by TCID50/mL using MDCK cells (5 × 104 cells/well in 96-well plates) through the Reed and Muench method ([@ref-41]; [@ref-45]). Non-linear regression of the dose response curves was performed to determine the 50% inhibitory effect on viral replication (EC~50~) for the extracts and reference compound (OST-car).

Functional antiviral assay---IC~50~ determination
-------------------------------------------------

For extracts with high influenza inhibition (80%) in the screening test, we performed a functional antiviral assay to determine the concentration required to inhibit 50% of the NA enzymatic activity (IC~50~). Wild-type and resistant strains of influenza A and B were tested against different concentrations of extracts (400 − 12.5 or 200 − 6.25 µg/mL), OST-car (1,000 − 0.01 nM) was used as control. This assay was done using the NA-Star™ assay kit (Life Technologies, USA), according to the manufacturer's instructions ([@ref-27]; [@ref-54]; [@ref-55]). The IC50 was calculated using a non-linear regression.

Statistical analysis
--------------------

The dose--response curves used to calculate the pharmacological parameter values were generated using Excel 2010 for Windows software (Microsoft) ([@ref-53]). All of the experiments were performed at least three times, and the results are displayed as the mean or the mean ± standard error (SEM).

Results
=======

Low cytotoxicity of the extracts
--------------------------------

The cells viability was the first analysis conducted, extracts with high cell toxicity *in vitro* were disregarded from the antiviral analysis. All the extracts produced were tested at 1 mg/mL in MDCK cell cultures. As control, we exposed MDCK to DMSO in the same proportion as we used in the extracts test, 1.0% V/V in culture medium, which did not affect the cells viability. The results showed that redox mitochondrial activity of the tested cells with extracts was inhibited at most by 20% after 48 h of exposure. Approximately 60% of extracts in ethyl acetate (EtOAc) and n-butanol (n-BuOH) solvent showed 90% of cell viability ([Table 2](#table-2){ref-type="table"}).

10.7717/peerj.5716/table-2

###### Percentage of cell viability and influenza inhibition (screening) after exposure to extracts in ethyl acetate (EtOAc) or n-butanol (n-BuOH) solvent.

![](peerj-06-5716-g003)

  **Extract**   **Taxon**                                             **Cell viability (%)**   **Screening (%)**                              
  ------------- ----------------------------------------------------- ------------------------ ------------------- -------- -------- -------- --------
  1             Unidentified filamentous green algae                  80 ± 1                   80 ± 2              87 ± 2   NI       82 ± 2   NI
  2             *Staurastrum* sp.                                     90 ± 2                   90 ± 2              85 ± 2   NI       82 ± 1   NI
  3             Unidentified filamentous green algae                  80 ± 1                   80 ± 2              NI       30 ± 4   NI       20 ± 2
  4             *Scenedesmus* sp.                                     90 ± 2                   90 ± 2              83 ± 3   NI       80 ± 3   NI
  5             *Leptolyngbya* sp.[^a^](#table-2fn1){ref-type="fn"}   90 ± 2                   90 ± 1              90 ± 2   NI       85 ± 2   NI
  6             Unidentified coccoid green algae                      90 ± 3                   90 ± 1              73 ± 2   NI       70 ± 4   NI
  7             Unidentified coccoid green algae                      90 ± 1                   90 ± 2              NI       NI       NI       NI
  8             *Scenedesmus abundans*                                90 ± 3                   90 ± 2              70 ± 4   NI       75 ± 1   NI
  9             *Scenedesmus vacuolatus*                              80 ± 2                   80 ± 2              NI       NI       NI       NI
  10            *Chlamydomonas angulosa*                              90 ± 1                   90 ± 1              NI       NI       NI       NI
  11            Chlorellaceae                                         80 ± 3                   80 ± 4              NI       NI       NI       NI
  12            Desmidiaceae                                          80 ± 1                   80 ± 2              60 ± 2   NI       56 ± 2   NI
  13            *Chlamydomonas sp.*                                   90 ± 3                   NP                  NI       NP       NI       NP
  14            *Selenastrum* sp.                                     80 ± 2                   NP                  NI       NP       NI       NP
  15            Scenedesmaceae                                        90 ± 3                   NP                  NI       NP       NI       NP
  16            Unidentified coccoid green algae                      90 ± 4                   NP                  NI       NP       NI       NP
  17            *Leptolyngbya* sp.[^a^](#table-2fn1){ref-type="fn"}   90 ± 3                   NP                  57 ± 2   NP       55 ± 2   NP
  18            *Desmodesmus armatus*                                 80 ± 3                   NP                  94 ± 2   NP       90 ± 2   NP
  19            *Symbiodinium* sp.                                    80 ± 2                   NP                  59 ± 4   NP       62 ± 4   NP
  20            *Chattonella* sp.                                     90 ± 1                   NP                  70 ± 5   NP       65 ± 2   NP
  21            Chlorellaceae                                         90 ± 4                   NP                  99 ± 1   NP       95 ± 1   NP
  22            *Desmodesmus perforates*                              80 ± 3                   NP                  58 ± 3   NP       50 ± 4   NP
  23            Chlorellaceae                                         90 ± 3                   NP                  46 ± 2   NP       38 ± 4   NP
  24            Desmidiaceae                                          90 ± 1                   NP                  84 ± 1   NP       82 ± 2   NP
  25            *Romeria* sp.[^a^](#table-2fn1){ref-type="fn"}        80 ± 3                   NP                  NI       NP       NI       NP
  26            *Nanofrustulum shiloi*                                90 ± 3                   NP                  66 ± 2   NP       60 ± 2   NP

**Notes.**

Cyanobacteria strains.

NPnot producedNIno inhibition

DMSO was used as a control at 0.01% V/V, and the cell viability remained at 100%.

The extracts inhibit influenza replication in more than 80%
-----------------------------------------------------------

After cytotoxicity analysis, we tested anti-influenza activity with all the extracts produced, EtOAc and n-BuOH. For this purpose, MDCK-infected cells were treated with 200 µg/mL of each extract. After 48 hpi, the supernatants were harvested and the influenza neuraminidase activity was analyzed. We observed that 17 extracts (16 in EtOAc and 1 in n-BuOH) inhibited the replication of influenza A strains, A(H1N1)pdm09-WT and A(H3N2)-WT. Seven of them (41%) resulted in more than 80% of inhibition ([Table 2](#table-2){ref-type="table"}). Just one n-BuOH extract from filamentous green algae was capable of inhibiting influenza replication, but at low levels. Despite this, an EtOAc extract obtained from another filamentous green alga was able to produce satisfactory inhibitory effects ([Table 2](#table-2){ref-type="table"}). All the EtOAc extract from Desmidiaceae family (*Staurastrum* sp.) and four out of six EtOAc extract from Scenedesmaceae family (*Scenedesmus* sp. and *Desmodesmus* sp.) were capable of inhibiting influenza replication with different magnitudes ([Table 2](#table-2){ref-type="table"}). Besides these, extract 21, obtained from Chlorellaceae green microalgae presented the greatest capacity to inhibit both influenza replications. However, others from the same family had limited or null capacity against this virus ([Table 2](#table-2){ref-type="table"}).

EC~50~ determination and SI evaluation
--------------------------------------

We determined the EC~50~ for seven marine extracts that *inhibited* in more than 80% the replication of both influenza A(H1N1)pdm09-WT and A(H3N2)-WT in the screening assay. The selective index (SI) is determined by the ratio between CC~50~ and EC~50~, and represents the relative effectiveness of the investigational product in inhibiting viral replication compared to inducing cell death. The EC~50~ of five extracts was less than 100 µg/mL with SI higher than 10.0 ([Table 3](#table-3){ref-type="table"}). The oseltamivir carboxylate (OST-car) was used as positive control with 177,667 and 66,625 SI for A(H1N1)pdm09-WT and A(H3N2)-WT, respectively. The SI values between a pool of molecules (extracts) and a molecule chemically defined (OST) are incomparable.
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###### The EC~50~, CC~50~ and SI values from extracts that inhibited influenza A replication higher than 80% in screening assay.

![](peerj-06-5716-g004)

  **Extract**   **Taxon**                                             **EC**~50~[^a^](#table-3fn1){ref-type="fn"}**(µg/mL)**   **CC**~50~[^b^](#table-3fn2){ref-type="fn"}**(µg/mL)**   **SI**[^c^](#table-3fn3){ref-type="fn"}            
  ------------- ----------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ----------------------------------------- -------- --------
  1             Unidentified filamentous green algae                  130                                                      150                                                      \>1,000                                   \>7.7    \>6.7
  2             *Staurastrum* sp.                                     70                                                       90                                                       \>1,000                                   \>14.3   \>11.1
  4             *Scenedesmus* sp.                                     130                                                      130                                                      \>1,000                                   \>7.7    \>7.7
  5             *Leptolyngbya* sp.[^d^](#table-3fn4){ref-type="fn"}   80                                                       85                                                       \>1,000                                   \>12.5   \>11.8
  18            *Desmodesmus armatus*                                 55                                                       60                                                       \>1,000                                   \>18.4   \>16.7
  21            Chlorellaceae                                         30                                                       40                                                       \>1,000                                   \>33.3   \>25.0
  24            Desmidiaceae                                          50                                                       55                                                       \>1,000                                   \>20.0   \>18.2
  OST-car                                                             0.012 µM                                                 0.032 µM                                                 2,132 µM                                  177,7    66,63

**Notes.**

EC~50~, the concentration required to reduced inhibition of viral infection-induced cytopathogenicity by 50%. Values represent the mean of duplicate samples from three independent experiments.

CC~50~, the concentration required to reduced normal, non-infected cell viability by 50%. Values represent the mean of duplicate samples from three independent experiments.

SI, selective index is determined by the ratio between CC~50~ and EC~50~.

Cyanobacteria strain.

OST-carOST carboxylate

Neuraminidase inhibition and IC~50~ determination
-------------------------------------------------

We performed a functional assay to analyze neuraminidase activity with all the seven extracts that inhibited influenza infection in more than 80%. IC50 is the concentration required to inhibit 50% of the influenza NA enzymatic activity. Thus, lower IC50 values imply in higher NA inhibition activity. Two of them, extracts from the cyanobacteria *Leptolyngbya* sp. (5) and microalga Chlorellaceae (21) inhibited influenza A NA activity with IC~50~ lower than 210 and 20 µg/mL, respectively ([Table 4](#table-4){ref-type="table"} and [Figs. 1A](#fig-1){ref-type="fig"}--[1D](#fig-1){ref-type="fig"}). The OST-car was used as control ([Table 4](#table-4){ref-type="table"} and [Figs. 1E](#fig-1){ref-type="fig"} and [1F](#fig-1){ref-type="fig"}). The HPLC and mass spectrum of extracts 5 and 21 are shown *S01-1* and *S01-2*, respectively. The mass spectrum of extract 5 (*S01-3*) indicated the presence of chlorinated compounds m/z = 214.9850 and 232.9946. On the other hand, the mass spectrum of extract 21 (*S01-4*) exhibited signals that indicated the presence of peptides, terpenes and/or alkaloids.
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###### The EC~50~ and IC~50~ values from extracts for OST-sensitive and resistant influenza A and B viruses.

![](peerj-06-5716-g005)

  **Influenza Virus strain**             **EC**~50~[^a^](#table-4fn1){ref-type="fn"}**(µg/mL)**   **IC**~50~[^b^](#table-4fn2){ref-type="fn"}**(µg/mL)**                      
  -------------------------------------- -------------------------------------------------------- -------------------------------------------------------- --------- -------- -----------
  A(H1N1)pdm09-WT                        80                                                       30                                                       149 ± 5   16 ± 2   0.1 ± 0.2
  A(H3N2)-WT                             85                                                       40                                                       162 ± 3   14 ± 3   2.1 ± 0.3
  A/Perth/261/2009 (A(H1N1)pdm09H275Y)   168                                                      50                                                       208 ± 4   72 ± 3   112 ± 2
  B/Phuket/3073/2013 Yam (WT)            215                                                      70                                                       207 ± 5   68 ± 2   2.8 ± 1
  B/Brisbane/60/2008 Vic (WT)            230                                                      75                                                       199 ± 4   41 ± 2   3 ± 0.5
  B/Perth/211/2001 Yam (WT)              200                                                      100                                                      179 ± 3   30 ± 5   5.0 ± 1
  B/Perth/211/2001 Yam (D197E)           260                                                      120                                                      184 ± 5   42 ± 4   10 ± 2

**Notes.**

EC~50~, the concentration required to reduced inhibition of viral infection-induced cytopathogenicity by 50%. Values represent the mean of duplicate samples from three independent experiments.

IC~50~, the concentration required to inhibit 50% of the NA enzymatic activity. Values represent the mean of duplicate samples from three independent experiments ± standard error.

OST-carOST carboxylate

![*Leptolyngbya sp*. and Chlorellaceae extracts inhibit influenza A and B OST-sensitive and -resistant viruses.\
The NA activity of the influenza A and B OST-sensitive and -resistant viruses were measured in the presence of different concentrations of extracts using a chemiluminescent substrate, NA-star kit (Life Technologies, Carlsbad, CA, USA). (A and B) Extract 5 (400 − 12.5 µg/mL). (C and D) Extract 21 (200 − 6.25 µg/mL). (E and F) OST carboxylate (1,000 − 0.01 nM), the reference compound was used as control. The results were obtained in relative luminescence units (RLU), but were converted to a percentage of the control for normalization of the data displayed. These experiments were performed three times and the means were expressed in the graphs.](peerj-06-5716-g001){#fig-1}

EC~50~ and IC~50~ determination to influenza A and B OST-sensitive and resistant viruses
----------------------------------------------------------------------------------------

The OST is the main antiviral used in clinics against Influenza A and B. The pressure imposed by this drug has led to the selection of resistant mutants ([@ref-10]; [@ref-27]; [@ref-54]). Thus, the search for new anti-influenza compounds that inhibits both types of influenza and their resistant strains or lineages is extremely important. Therefore, we tested extracts from *Leptolyngbya* sp. (5) and Chlorellaceae (21) against replication and NA activity of influenza A OST-resistant ([Table 4](#table-4){ref-type="table"} and [Figs. 1B](#fig-1){ref-type="fig"} and [1D](#fig-1){ref-type="fig"}) and B OST-sensitive and resistant ([Table 4](#table-4){ref-type="table"} and [Figs. 1A](#fig-1){ref-type="fig"}--[1D](#fig-1){ref-type="fig"}) viruses. The OST-car was used as control ([Table 4](#table-4){ref-type="table"} and [Figs. 1E](#fig-1){ref-type="fig"} and [1F](#fig-1){ref-type="fig"}). Both extracts inhibited influenza replication and NA activity with low EC~50~ and IC~50~, including for OST-resistant strains and lineages ([Table 4](#table-4){ref-type="table"} and [Fig. 1](#fig-1){ref-type="fig"}). The raw data of the IC~50~ calculations are provided in *S02*.

Discussion
==========

Influenza virus is the most important pathogen that causes acute lower respiratory infections ([@ref-62]). The OST, a neuraminidase inhibitor, is the main anti-influenza used in clinics, but strains resistant to this molecule have been in clinical treatments reported worldwide, mandating the development of novel therapeutics ([@ref-10]; [@ref-27]; [@ref-54]).

Microalgae and cyanobacteria are huge natural sources of compounds of high nutritional and medicinal value. These marine and freshwater organisms are a rich source of bioactive compounds such as vitamins, proteins with essential amino acids, polysaccharides, fatty acids, minerals, photosynthetic pigments, enzymes, and fiber ([@ref-14]; [@ref-36]).

Cyanobacteria are a promising yet underexplored source for novel natural products, including antiviral compounds. More detailed screening studies have identified antiviral activities on sulfoglycolipids and lectins ([@ref-28]; [@ref-37]; [@ref-38]; [@ref-49]; [@ref-65]). However, chemically different groups of compounds in cyanobacteria include alkaloids, lipopeptides, macrolides, and others ([@ref-26]). Several studies have been conducted to test microalgae compounds against pathogenic human viruses. Antiviral compounds extracted from microalgae are mainly polysaccharides. Polyunsaturated aldehydes, carotenoid, terpenes, and alkaloids are other bioactive molecules produced by microalgae ([@ref-11]; [@ref-29]; [@ref-46]).

Thus, we tested anti-influenza activity of extracts derived from microalgae and cyanobacteria collected from Paraguaçu River, Shallow Lake System of Lençois Maranhenses, Guanabara Bay estuary and Abrolhos coral reefs.

In screening assay we observed that seven extracts were able to inhibit seasonal influenza A replication viruses in more than 80%, five of them with SI higher than 10. Aqueous and methanolic extracts of cultured cyanobacteria of Microcystis and Spirulina genus inhibit influenza replication with SI comparable to ethyl acetate extract from *Leptolyngbya* sp. (cyanobacteria) ([@ref-4]; [@ref-65]). Besides that, one sulfated polysaccharide purified from the marine microalga, *Gyrodinium impudium*, inhibits influenza A infection with SI higher than 200, but not influenza B ([@ref-25]).

In addition, *Trichodesmium erythraeum* (Cyanobacterial) aplysiatoxin-related compounds debromoaplysiatoxin and 3-methoxydebromoaplysiatoxin displayed anti-CHIKV effects at concentrations that resulted in minimal cytotoxicity ([@ref-18]). Activity against influenza A has been found for the cyclic depsipeptides named ichthyopeptins A and B isolated from cyanobacterium *Microcystis ichthyolabe* ([@ref-64]). *Nostoc ellipsosporum* (Cyanobacterial) lectin named Cyanovirin-N (CV-N) is a potent anti-influenza A as well as anti-influenza B. The CV-N bounds directly to the viruses, inactivating them ([@ref-51]). The green algae and land plants form a monophyletic lineage named chlorophytes, the first is an ancestor of the second ([@ref-7]). Therefore, it is possible that they present similar primary and secondary metabolites ([@ref-5]; [@ref-23]). A broad spectrum of plant extracts inhibit the influenza replication, including extracts from ethyl acetate solvent, with SI comparable to that observed in extracts 2, 4, 18, 21 and 24, from green microalgae *Staurastrum* sp., *Scenedesmus* sp., *Desmodesmus armatus*, Chlorellaceae and Desmidiaceae, respectively ([@ref-20]; [@ref-63]).

The Chlorellaceae family, mainly *Chlorella* genus, produce a broad spectrum of carotenoids with different anti-angiogenic activities, cardioprotective, anti-cancer, anti-diabetic, anti-inflammatory, anti-oxidant and others ([@ref-46]). Furthermore, retinoids, products of carotenoid metabolism, inhibit mumps virus replication preventing the infection of healthy cells by induction of a retinoid inducible gene I (RIG-I), retinoic acid receptor (RAR) and interferon ([@ref-56]). Interferon-induced transmembrane proteins (IFITMs) inhibit infection of diverse enveloped viruses, such as West Nile, dengue, Zika and influenza by blocking virus-endosome fusion ([@ref-2]; [@ref-8]; [@ref-34]; [@ref-47]). Thus, it is possible that the Chlorellaceae (microalgal) extract leads to the increase of this cell restrictive protein, suggesting a mechanism of action for the influenza replication inhibitory effect.

In addition, two extracts from *Leptolyngbya* sp. (cyanobacteria) and Chlorellaceae family (microalgae) inhibited the replication and neuraminidase activity of influenza A and B viruses, including OST-sensitive and resistant strains and lineages. These results were similar to that observed for a water extract of *Taxodium distichum* (Cupressaceae family), which presented excellent efficacy against both influenza viruses, particularly OST-resistant clinical isolates and swine-origin influenza strains ([@ref-21]). These data indicate that microalgae and cyanobacteria are a promising source of anti-influenza natural products.

As mentioned before, there are several cellular factors described as restricting the replication of influenza virus ([@ref-58]). Furthermore, despite the inhibitory effect against neuraminidase activity, the extracts may have molecules capable of inhibiting different stages of the viral replicative cycle, and/or they can activate host cell restriction factors, but these effects will still be investigated. Thus, microalgae and cyanobacteria are important marine and freshwater microorganisms for bioprospecting in antiviral research. The microorganisms evaluated in this study were collected in Brazil, but they are not exclusively Brazilian. It may be relevant to compare the metabolites production of the same taxonomic groups collected in different parts of the world.

Conclusions
===========

In this study we tested anti-influenza activity of extracts derived by microalgae and cyanobacteria collected from Paraguaçu River, Shallow Lake System of Lençois Maranhenses, Guanabra Bay estuary and Abrolhos coral reefs. We found seven extracts, in ethyl acetate solvent, that inhibit seasonal influenza A and B replication in MDCK cells in more than 80%. Two extracts from *Leptolyngbya* sp. (cyanobacteria) and Chlorellaceae family (microalgae) inhibited influenza A and B replication and neuraminidase activity, from OST-sensitive and resistance strains and lineages. Thus, these organisms are important for bioprospecting in antiviral research.
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